Literature DB >> 18631217

Meningomyelitis in dogs: a retrospective review of 28 cases (1999 to 2007).

J F Griffin1, J M Levine, G J Levine, G T Fosgate.   

Abstract

OBJECTIVES: To characterise dogs with meningomyelitis and to compare signalment, body temperature and vaccination status to a representative control group.
METHODS: Dogs with meningomyelitis were identified retrospectively. Signalment, history, vaccination status, body temperature, severity of neurological dysfunction (modified Frankel score), diagnostic procedures, aetiology, survival to discharge and long-term survival were analysed.
RESULTS: Affected dogs were younger (P<0.05) and more frequently hound or toy breeds (P<0.05) when compared with controls. Hound and toy breed dogs less than or equal to three years of age had a 13 times higher odds of meningomyelitis compared with other breeds (P<0.001). General proprioceptive ataxia, limb paresis and paraspinal hyperaesthesia were the most common clinical signs. Meningomyelitis of unknown aetiology and granulomatous meningomyelitis were the most common diagnoses. The median time to death or continued follow-up in dogs alive at discharge was 213 days. Meningomyelitis resulted in death or euthanasia in 14 of 28 dogs. Clinical signs improved or resolved in seven of 28 dogs. CLINICAL SIGNIFICANCE: Meningomyelitis is a differential diagnosis for dogs with clinical signs of myelopathy. Young dogs and toy or hound breeds seem to be predisposed. Clinical signs of meningomyelitis improve or resolve in some dogs.

Entities:  

Mesh:

Year:  2008        PMID: 18631217     DOI: 10.1111/j.1748-5827.2008.00588.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  3 in total

1.  Clinical presentation, diagnostic findings and outcome in dogs diagnosed withpresumptive spinal-only meningoen-cephalomyelitis of unknown origin.

Authors:  I Cornelis; H A Volk; L Van Ham; S De Decker
Journal:  J Small Anim Pract       Date:  2017-03       Impact factor: 1.522

2.  Testing for Bartonella ssp. DNA in cerebrospinal fluid of dogs with inflammatory central nervous system disease.

Authors:  Lisa R Bartner; Stephanie McGrath; Adam Drury; Annie V Chen; Arianne Morris; Melissa Brewer; Meri Hall; Michael R Lappin
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

3.  Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders.

Authors:  Christopher L Mariani; Carolyn J Nye; Debra A Tokarz; Lauren Green; Jeanie Lau; Natalia Zidan; Peter J Early; Julien Guevar; Karen R Muñana; Natasha J Olby; Sarita Miles
Journal:  J Vet Intern Med       Date:  2019-09-24       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.